Davide Bettelli

Davide Bettelli has extensive experience in the pharmaceutical industry, beginning a career in May 1990 as an ISF at Chiesi Farmaceutici and continuing with Wyeth from September 1992 to September 1999, where roles included ISF and ISF Haematology & Transplant. Following that, Davide joined Genzyme in September 2005, contributing as Field Area Manager for Renal in North Italy, as well as holding sales and marketing management positions focused on rare diseases such as CMR and Fabry. Since March 2013, Davide has been with Genzyme a Sanofi Company, serving as Head of the Business Unit for Fabry Disease and Endo Cardiovascular. In January 2020, Davide transitioned to Sanofi Genzyme as Commercial Lead for Pompe Disease, while also overseeing franchises for both Fabry disease and Endocrinology and Pompe disease.